Elejalde syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Elejalde syndrome
Synonyms	Neuroectodermal melanolysosomal disease
Pronounce	N/A
Specialty	N/A
Symptoms	Hypopigmentation, neurological abnormalities, developmental delay
Complications	N/A
Onset	Infancy
Duration	Lifelong
Types	N/A
Causes	Genetic mutation
Risks	Family history of the condition
Diagnosis	Genetic testing, clinical evaluation
Differential diagnosis	Chediak-Higashi syndrome, Griscelli syndrome
Prevention	N/A
Treatment	Symptomatic and supportive care
Medication	N/A
Prognosis	Variable, often poor
Frequency	Rare
Deaths	N/A

Elejalde syndrome, also known as neuroectodermal melanolysosomal disease, is a rare genetic disorder characterized by a combination of neurological, dermatological, and ocular abnormalities. It is an autosomal recessive condition, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder.

Clinical Features

Individuals with Elejalde syndrome typically present with a range of symptoms that can vary in severity. Common clinical features include:

• Neurological abnormalities: These may include developmental delay, intellectual disability, and seizures.
• Dermatological features: Patients often have hypopigmentation of the skin and hair, leading to a lighter appearance compared to unaffected family members.
• Ocular abnormalities: These can include nystagmus, strabismus, and other vision problems.

Pathophysiology

Elejalde syndrome is caused by mutations in genes involved in the development and function of melanosomes, which are specialized organelles responsible for the production and storage of melanin. The exact genetic mutations responsible for Elejalde syndrome have not been fully elucidated, but they are believed to affect the lysosomal and melanosomal pathways.

Diagnosis

Diagnosis of Elejalde syndrome is primarily based on clinical evaluation and the identification of characteristic symptoms. Genetic testing can confirm the diagnosis by identifying mutations in the relevant genes. Differential diagnosis may include other conditions with similar presentations, such as Chediak-Higashi syndrome and Griscelli syndrome.

Management

There is currently no cure for Elejalde syndrome, and treatment is primarily supportive. Management strategies may include:

• Neurological care: Anticonvulsant medications may be used to control seizures.
• Dermatological care: Sun protection and skin care may be recommended to manage hypopigmentation.
• Ophthalmological care: Regular eye examinations and corrective lenses may be necessary to address vision problems.

Genetic Counseling

Genetic counseling is recommended for families affected by Elejalde syndrome. As an autosomal recessive disorder, there is a 25% chance with each pregnancy that two carrier parents will have an affected child. Carrier testing and prenatal diagnosis may be options for at-risk families.

See also

• Genetic disorder
• Autosomal recessive
• Melanin
• Lysosome
• Chediak-Higashi syndrome
• Griscelli syndrome